Christopher Dixon

Christopher Dixon has a strong background in information technology, having held various roles in leading pharmaceutical companies. Christopher most recently served as the Senior Director of Information Technology at Taysha Gene Therapies since December 2020. Prior to that, they worked at Novartis Gene Therapies as the Director of EUX from September 2020 to November 2020. Christopher also has extensive experience at AveXis, Inc., where they held multiple positions including Director of Information Technology from August 2018 to September 2020, Senior Information Technology Administrator from February 2017 to September 2020, and IT Project Administrator from August 2016 to February 2017. Christopher began their career at Lundbeck in 2007, where they served as an IT Applications Specialist from October 2013 to August 2016 and as an Information Technology professional from June 2007 to August 2016.

Christopher Dixon attended Northeastern Illinois University from 1999 to 2004, where they obtained a Bachelor of Computer Science degree. Christopher'sfield of study during this time was specifically focused on computer programming and specific applications.